Notice

Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

General

3.Responses to Inquiries regarding the Inclusion of Zymfentra in PBM Formularies

New
2024-08-13

IR

4.Collecting shareholder’s opinions to examine whether to proceed with the merger with Celltrion Pharm

New
2024-08-09
No results found.
Tag
ABOUT US BUSINESS ESGIR CAREERS
Privacy PolicyContact Us

41-13 Nonhyeon-dong, Gangnam-gu, Seoul, South Korea

+82 111-1234-1254

© PULIP COMMUNICATIONS Co., Ltd